Invitation to Bid - Tab Rivaroxaban 20mg,Bosentan 62.5 mg tab,N Butyl cyanoacrylate 0.5ml Inj,Tobramycin 300 mcg respul in PANCHKULA, HARYANA

The eligibility requirements include being a registered entity, possessing prior experience in supplying pharmaceutical products, and meeting specific turnover criteria. Additionally, bidders must provide necessary documentation to support their claims for exemptions if requested.

Bidders must submit certifications reflecting their compliance with technical specifications, an OEM Authorization Certificate, and proof of past performance related to similar pharmaceutical supplies. Any additional supporting documentation requested must also be included.

The registration process requires bidders to sign up on the official tender platform, submit relevant business information, and comply with the necessary verification checks as detailed in the documentation.

Accepted document formats include PDF and DOC. Bidders should ensure that all submitted certifications and compliance documents adhere to these formats to avoid disqualification.

The technical specifications require that all drugs meet safety and efficacy standards as outlined in the BoQ. Detail in compliance certificates must reflect alignment with specifications for Rivaroxaban, Bosentan, N-Butyl cyanoacrylate, and other medications listed.

Bidders must comply with international quality standards pertaining to pharmaceuticals, ensuring that all items meet established health regulations and guidelines prior to delivery.

Compliance requirements include adherence to all listed specifications, submission of required documents, and demonstration of quality assurance processes that meet industry standards.

Submissions must undergo evaluation that includes testing for quality and safety of the pharmaceuticals offered. This may involve third-party validation or inspection as deemed necessary by the department.

The EMD required for this tender is ₹8315. This amount ensures the bid's seriousness and is returned after the evaluation, subject to compliance with tender conditions.

Yes, successful bidders will be required to provide performance security to ensure fulfillment of contract obligations, as outlined in the tender documentation.

Payment terms will be specified in the contract after award, typically involving a payment schedule tied to delivery milestones and acceptance of goods.

The evaluation and selection process will be item-wise based, focusing on compliance with submission requirements, technical specifications, pricing competitiveness, and overall past performance.

Bidders will be notified of the results through the tender platform or via official communication channels as defined in the tender documentation upon conclusion of the evaluation process.

MSEs have preferential consideration during the evaluation process, allowing them to compete effectively and potentially enjoy relaxed eligibility criteria for certain aspects of the tender requirements.

Yes, startups may benefit from easier qualification criteria and consideration of their unique capabilities in the context of this tender.

Yes, bidders are encouraged to ensure their submissions contribute to the 'Make in India' initiative, focusing on local procurement and manufacturing processes whenever possible.

Bidders must adhere to local content requirements as per relevant procurement policies that promote the use of domestically sourced materials and services in their bids.